From the Departments of Pharmacology and Toxicology and.
J Biol Chem. 2014 Mar 14;289(11):7470-82. doi: 10.1074/jbc.M113.518472. Epub 2014 Jan 28.
Collapsin response mediator protein 2 (CRMP2) is traditionally viewed as an axonal growth protein involved in axon/dendrite specification. Here, we describe novel functions of CRMP2. A 15-amino acid peptide from CRMP2, fused to the TAT cell-penetrating motif of the HIV-1 protein, TAT-CBD3, but not CBD3 without TAT, attenuated N-methyl-d-aspartate receptor (NMDAR) activity and protected neurons against glutamate-induced Ca(2+) dysregulation, suggesting the key contribution of CRMP2 in these processes. In addition, TAT-CBD3, but not CBD3 without TAT or TAT-scramble peptide, inhibited increases in cytosolic Ca(2+) mediated by the plasmalemmal Na(+)/Ca(2+) exchanger (NCX) operating in the reverse mode. Co-immunoprecipitation experiments revealed an interaction between CRMP2 and NMDAR as well as NCX3 but not NCX1. TAT-CBD3 disrupted CRMP2-NMDAR interaction without change in NMDAR localization. In contrast, TAT-CBD3 augmented the CRMP2-NCX3 co-immunoprecipitation, indicating increased interaction or stabilization of a complex between these proteins. Immunostaining with an anti-NCX3 antibody revealed that TAT-CBD3 induced NCX3 internalization, suggesting that both reverse and forward modes of NCX might be affected. Indeed, the forward mode of NCX, evaluated in experiments with ionomycin-induced Ca(2+) influx into neurons, was strongly suppressed by TAT-CBD3. Knockdown of CRMP2 with short interfering RNA (siRNA) prevented NCX3 internalization in response to TAT-CBD3 exposure. Moreover, CRMP2 down-regulation strongly attenuated TAT-CBD3-induced inhibition of reverse NCX. Overall, our results demonstrate that CRMP2 interacts with NCX and NMDAR and that TAT-CBD3 protects against glutamate-induced Ca(2+) dysregulation most likely via suppression of both NMDAR and NCX activities. Our results further clarify the mechanism of action of TAT-CBD3 and identify a novel regulatory checkpoint for NMDAR and NCX function based on CRMP2 interaction with these proteins.
collapsin 反应介体蛋白 2 (CRMP2) 传统上被视为一种参与轴突/树突特化的轴突生长蛋白。在这里,我们描述了 CRMP2 的新功能。来自 CRMP2 的 15 个氨基酸肽与 HIV-1 蛋白的 TAT 细胞穿透结构域融合,即 TAT-CBD3,但与没有 TAT 的 CBD3 或没有 TAT 的 TAT 乱序肽不同,TAT-CBD3 减弱了 N-甲基-D-天冬氨酸受体 (NMDAR) 的活性并保护神经元免受谷氨酸诱导的 Ca(2+) 失调,这表明 CRMP2 在这些过程中起着关键作用。此外,TAT-CBD3 但不是没有 TAT 的 CBD3 或没有 TAT 的 TAT 乱序肽抑制了质膜 Na(+)/Ca(2+) 交换体 (NCX) 以反向模式介导的细胞质 Ca(2+) 的增加。共免疫沉淀实验显示 CRMP2 与 NMDAR 以及 NCX3 之间存在相互作用,但与 NCX1 没有相互作用。TAT-CBD3 破坏了 CRMP2-NMDAR 相互作用,而 NMDAR 定位没有改变。相反,TAT-CBD3 增强了 CRMP2-NCX3 的共免疫沉淀,表明这些蛋白之间的相互作用或复合物的稳定性增加。用抗 NCX3 抗体进行免疫染色显示,TAT-CBD3 诱导 NCX3 内化,表明 NCX 的反向和正向模式可能都受到影响。事实上,用离子霉素诱导神经元内 Ca(2+) 流入进行实验评估时,NCX 的正向模式被 TAT-CBD3 强烈抑制。用短干扰 RNA (siRNA) 敲低 CRMP2 可防止 TAT-CBD3 暴露时 NCX3 的内化。此外,CRMP2 下调强烈减弱了 TAT-CBD3 诱导的反向 NCX 抑制。总的来说,我们的结果表明 CRMP2 与 NCX 和 NMDAR 相互作用,TAT-CBD3 可能通过抑制 NMDAR 和 NCX 活性来保护神经元免受谷氨酸诱导的 Ca(2+) 失调。我们的结果进一步阐明了 TAT-CBD3 的作用机制,并确定了基于 CRMP2 与这些蛋白相互作用的 NMDAR 和 NCX 功能的新调节检查点。